NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,000 | -78.9% | 108 | -76.4% | 0.01% | -33.3% |
Q1 2022 | $38,000 | +22.6% | 457 | +10.7% | 0.01% | +28.6% |
Q4 2021 | $31,000 | -44.6% | 413 | -14.1% | 0.01% | -46.2% |
Q3 2021 | $56,000 | -45.1% | 481 | +5.0% | 0.01% | -43.5% |
Q2 2021 | $102,000 | -11.3% | 458 | -47.2% | 0.02% | -20.7% |
Q1 2021 | $115,000 | -33.9% | 868 | -13.8% | 0.03% | -9.4% |
Q4 2020 | $174,000 | +61.1% | 1,007 | +3.4% | 0.03% | +39.1% |
Q3 2020 | $108,000 | +96.4% | 974 | +5.5% | 0.02% | +91.7% |
Q2 2020 | $55,000 | -14.1% | 923 | -2.1% | 0.01% | -29.4% |
Q1 2020 | $64,000 | -12.3% | 943 | +8.8% | 0.02% | +6.2% |
Q4 2019 | $73,000 | +19.7% | 867 | +6.6% | 0.02% | +45.5% |
Q3 2019 | $61,000 | +144.0% | 813 | 0.0% | 0.01% | +83.3% |
Q2 2019 | $25,000 | -35.9% | 813 | 0.0% | 0.01% | -14.3% |
Q1 2019 | $39,000 | +44.4% | 813 | 0.0% | 0.01% | +16.7% |
Q4 2018 | $27,000 | -35.7% | 813 | 0.0% | 0.01% | -25.0% |
Q3 2018 | $42,000 | +68.0% | 813 | 0.0% | 0.01% | +60.0% |
Q2 2018 | $25,000 | +38.9% | 813 | 0.0% | 0.01% | +25.0% |
Q1 2018 | $18,000 | +12.5% | 813 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $16,000 | – | 813 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |